BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23913591)

  • 21. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
    Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
    J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
    Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of occult paragangliomas in asymptomatic carriers of SDHD and SDHB gene mutations.
    Heesterman BL; Bayley JP; Tops CM; Hes FJ; van Brussel BT; Corssmit EP; Hamming JF; van der Mey AG; Jansen JC
    Eur J Hum Genet; 2013 Apr; 21(4):469-70. PubMed ID: 22948026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pheochromocytoma: the expanding genetic differential diagnosis.
    Bryant J; Farmer J; Kessler LJ; Townsend RR; Nathanson KL
    J Natl Cancer Inst; 2003 Aug; 95(16):1196-204. PubMed ID: 12928344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial paraganglioma syndromes.
    Chetty R
    J Clin Pathol; 2010 Jun; 63(6):488-91. PubMed ID: 20498024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma.
    Kunst HP; Rutten MH; de Mönnink JP; Hoefsloot LH; Timmers HJ; Marres HA; Jansen JC; Kremer H; Bayley JP; Cremers CW
    Clin Cancer Res; 2011 Jan; 17(2):247-54. PubMed ID: 21224366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3.
    Malinoc A; Sullivan M; Wiech T; Schmid KW; Jilg C; Straeter J; Deger S; Hoffmann MM; Bosse A; Rasp G; Eng C; Neumann HP
    Endocr Relat Cancer; 2012 Jun; 19(3):283-90. PubMed ID: 22351710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraganglioma syndrome: SDHB, SDHC, and SDHD mutations in head and neck paragangliomas.
    Schiavi F; Savvoukidis T; Trabalzini F; Grego F; Piazza M; Amistà P; Demattè S; Del Piano A; Cecchini ME; Erlic Z; De Lazzari P; Mantero F; Opocher G
    Ann N Y Acad Sci; 2006 Aug; 1073():190-7. PubMed ID: 17102086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma.
    McWhinney SR; Pilarski RT; Forrester SR; Schneider MC; Sarquis MM; Dias EP; Eng C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5694-9. PubMed ID: 15531530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.
    Fishbein L; Nathanson KL
    Cancer Genet; 2012; 205(1-2):1-11. PubMed ID: 22429592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
    Piccini V; Rapizzi E; Bacca A; Di Trapani G; Pulli R; Giachè V; Zampetti B; Lucci-Cordisco E; Canu L; Corsini E; Faggiano A; Deiana L; Carrara D; Tantardini V; Mariotti S; Ambrosio MR; Zatelli MC; Parenti G; Colao A; Pratesi C; Bernini G; Ercolino T; Mannelli M
    Endocr Relat Cancer; 2012 Apr; 19(2):149-55. PubMed ID: 22241717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Head and neck paragangliomas].
    Nielsen SB; Sunde L; Bundgaard T
    Ugeskr Laeger; 2014 Dec; 176(52):. PubMed ID: 25534338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
    Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas.
    Mhatre AN; Li Y; Feng L; Gasperin A; Lalwani AK
    Clin Genet; 2004 Nov; 66(5):461-6. PubMed ID: 15479192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
    Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of mutations in genes that predispose to hereditary paragangliomas and pheochromocytomas.
    Lefebvre S; Borson-Chazot F; Boutry-Kryza N; Wion N; Schillo F; Peix JL; Brunaud L; Finat A; Calender A; Giraud S
    Horm Metab Res; 2012 May; 44(5):334-8. PubMed ID: 22517554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study.
    de Vos B; Rijken JA; Adank MA; Hoksbergen AWJ; Bayley JP; Leemans CR; Hensen EF
    Clin Otolaryngol; 2018 Jun; 43(3):841-845. PubMed ID: 29292578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
    Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency.
    Bayley JP; Devilee P; Taschner PE
    BMC Med Genet; 2005 Nov; 6():39. PubMed ID: 16288654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.